Belantamab mafodotin, pomalidomide, and dexamethasone for triple class exposed
Multiple studies report on survival outcomes and therapies for multiple myeloma, including retrospective analyses, phase trials, and real-world data, highlighting advancements in treatment strategies and overall survival improvements.
© Copyright 2025. All Rights Reserved by MedPath